{"title":"多参数磁共振成像中检测不到的前列腺癌的临床特征和病理特征:单中心回顾性研究。","authors":"Takahiro Yamamoto, Hiroaki Okada, Nozomu Matsunaga, Makoto Endo, Toyonori Tsuzuki, Keishi Kajikawa, Kojiro Suzuki","doi":"10.25259/JCIS_37_2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The objectives of this study were to clarify the pathological features of clinically significant prostate cancer (csPC) that is undetectable on multiparametric magnetic resonance imaging (mpMRI).</p><p><strong>Material and methods: </strong>This single-center and retrospective study enrolled 33 men with prostate cancer (PC), encompassing 109 PC lesions, who underwent mpMRI before radical prostatectomy. Two radiologists independently assessed the mpMR images of all lesions and compared them with the pathological findings of PC. All PC lesions were marked on resected specimens using prostate imaging reporting and data system version 2.1 and classified into magnetic resonance imaging (MRI)-detectable and MRI-undetectable PC lesions. Each lesion was classified into csPC and clinically insignificant PC. Pathological characteristics were compared between MRI-detectable and MRI-undetectable csPC. Statistical analysis was performed to identify factors associated with MRI detectability. A logistic regression model was used to determine the factors associated with MRI-detectable and MRI-undetectable csPC.</p><p><strong>Results: </strong>Among 109 PC lesions, MRI-detectable and MRI-undetectable PCs accounted for 31% (34/109) and 69% (75/109) of lesions, respectively. All MRI-detectable PCs were csPC. MRI-undetectable PCs included 30 cases of csPC (40%). The detectability of csPC on mpMRI was 53% (34/64). The MRI-undetectable csPC group had a shorter major diameter (10.6 ± 6.6 mm vs. 19.0 ± 6.9 mm, <i>P</i> < 0.001), shorter minor diameter (5.7 ± 2.9 mm vs. 10.7 ± 3.4 mm, <i>P</i> < 0.001), and lower percentage of lesions with Gleason pattern 5 (17% vs. 71%, <i>P</i> < 0.001). Shorter minor diameter (odds ratio [OR], 2.62; <i>P</i> = 0.04) and lower percentage of Gleason pattern 5 (OR, 24; <i>P</i> = 0.01) were independent predictors of MRI-undetectable csPC.</p><p><strong>Conclusion: </strong>The pathological features of MRI-undetectable csPC included shorter minor diameter and lower percentage of Gleason pattern 5. csPC with shorter minor diameter may not be detected on mpMRI. Some MRI-undetectable csPC lesions exhibited sufficient size and Gleason pattern 5, emphasizing the need for further understanding of pathological factors contributing to MRI detectability.</p>","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11225522/pdf/","citationCount":"0","resultStr":"{\"title\":\"Clinical characteristics and pathological features of undetectable clinically significant prostate cancer on multiparametric magnetic resonance imaging: A single-center and retrospective study.\",\"authors\":\"Takahiro Yamamoto, Hiroaki Okada, Nozomu Matsunaga, Makoto Endo, Toyonori Tsuzuki, Keishi Kajikawa, Kojiro Suzuki\",\"doi\":\"10.25259/JCIS_37_2024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>The objectives of this study were to clarify the pathological features of clinically significant prostate cancer (csPC) that is undetectable on multiparametric magnetic resonance imaging (mpMRI).</p><p><strong>Material and methods: </strong>This single-center and retrospective study enrolled 33 men with prostate cancer (PC), encompassing 109 PC lesions, who underwent mpMRI before radical prostatectomy. Two radiologists independently assessed the mpMR images of all lesions and compared them with the pathological findings of PC. All PC lesions were marked on resected specimens using prostate imaging reporting and data system version 2.1 and classified into magnetic resonance imaging (MRI)-detectable and MRI-undetectable PC lesions. Each lesion was classified into csPC and clinically insignificant PC. Pathological characteristics were compared between MRI-detectable and MRI-undetectable csPC. Statistical analysis was performed to identify factors associated with MRI detectability. A logistic regression model was used to determine the factors associated with MRI-detectable and MRI-undetectable csPC.</p><p><strong>Results: </strong>Among 109 PC lesions, MRI-detectable and MRI-undetectable PCs accounted for 31% (34/109) and 69% (75/109) of lesions, respectively. All MRI-detectable PCs were csPC. MRI-undetectable PCs included 30 cases of csPC (40%). The detectability of csPC on mpMRI was 53% (34/64). The MRI-undetectable csPC group had a shorter major diameter (10.6 ± 6.6 mm vs. 19.0 ± 6.9 mm, <i>P</i> < 0.001), shorter minor diameter (5.7 ± 2.9 mm vs. 10.7 ± 3.4 mm, <i>P</i> < 0.001), and lower percentage of lesions with Gleason pattern 5 (17% vs. 71%, <i>P</i> < 0.001). Shorter minor diameter (odds ratio [OR], 2.62; <i>P</i> = 0.04) and lower percentage of Gleason pattern 5 (OR, 24; <i>P</i> = 0.01) were independent predictors of MRI-undetectable csPC.</p><p><strong>Conclusion: </strong>The pathological features of MRI-undetectable csPC included shorter minor diameter and lower percentage of Gleason pattern 5. csPC with shorter minor diameter may not be detected on mpMRI. Some MRI-undetectable csPC lesions exhibited sufficient size and Gleason pattern 5, emphasizing the need for further understanding of pathological factors contributing to MRI detectability.</p>\",\"PeriodicalId\":15512,\"journal\":{\"name\":\"Journal of Clinical Imaging Science\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2024-06-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11225522/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Imaging Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25259/JCIS_37_2024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Imaging Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/JCIS_37_2024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
摘要
研究目的本研究旨在阐明多参数磁共振成像(mpMRI)无法检测到的具有临床意义的前列腺癌(csPC)的病理特征:这项单中心回顾性研究共纳入33名前列腺癌(PC)男性患者,包括109个PC病灶,他们在根治性前列腺切除术前接受了mpMRI检查。两名放射科医生独立评估了所有病灶的 mpMR 图像,并将其与 PC 的病理结果进行了比较。使用前列腺成像报告和数据系统 2.1 版对切除标本上的所有 PC 病灶进行标记,并将其分为磁共振成像(MRI)可检测到的 PC 病灶和磁共振成像无法检测到的 PC 病灶。每个病灶又被分为 csPC 和临床意义不明显的 PC。对磁共振成像可检测到的 csPC 和磁共振成像无法检测到的 csPC 的病理特征进行比较。进行统计分析以确定与磁共振成像可检测性相关的因素。采用逻辑回归模型确定与MRI可检测和MRI不可检测csPC相关的因素:在109个PC病灶中,MRI可检测到和MRI无法检测到的PC分别占31%(34/109)和69%(75/109)。所有核磁共振检测出的 PC 均为 csPC。MRI 检测不到的 PC 包括 30 例 csPC(40%)。mpMRI 对 csPC 的检测率为 53%(34/64)。MRI 检测不到的 csPC 组主要直径较短(10.6 ± 6.6 mm vs. 19.0 ± 6.9 mm,P < 0.001),次要直径较短(5.7 ± 2.9 mm vs. 10.7 ± 3.4 mm,P < 0.001),Gleason 模式 5 的病变比例较低(17% vs. 71%,P < 0.001)。较短的小直径(几率比 [OR],2.62;P = 0.04)和较低的 Gleason 模式 5 百分比(OR,24;P = 0.01)是 MRI 检测不到 csPC 的独立预测因素:结论:MRI检测不到的csPC的病理特征包括较短的小直径和较低的Gleason模式5比例。一些MRI检测不到的csPC病灶表现出足够的大小和Gleason模式5,这强调了进一步了解导致MRI可检测性的病理因素的必要性。
Clinical characteristics and pathological features of undetectable clinically significant prostate cancer on multiparametric magnetic resonance imaging: A single-center and retrospective study.
Objectives: The objectives of this study were to clarify the pathological features of clinically significant prostate cancer (csPC) that is undetectable on multiparametric magnetic resonance imaging (mpMRI).
Material and methods: This single-center and retrospective study enrolled 33 men with prostate cancer (PC), encompassing 109 PC lesions, who underwent mpMRI before radical prostatectomy. Two radiologists independently assessed the mpMR images of all lesions and compared them with the pathological findings of PC. All PC lesions were marked on resected specimens using prostate imaging reporting and data system version 2.1 and classified into magnetic resonance imaging (MRI)-detectable and MRI-undetectable PC lesions. Each lesion was classified into csPC and clinically insignificant PC. Pathological characteristics were compared between MRI-detectable and MRI-undetectable csPC. Statistical analysis was performed to identify factors associated with MRI detectability. A logistic regression model was used to determine the factors associated with MRI-detectable and MRI-undetectable csPC.
Results: Among 109 PC lesions, MRI-detectable and MRI-undetectable PCs accounted for 31% (34/109) and 69% (75/109) of lesions, respectively. All MRI-detectable PCs were csPC. MRI-undetectable PCs included 30 cases of csPC (40%). The detectability of csPC on mpMRI was 53% (34/64). The MRI-undetectable csPC group had a shorter major diameter (10.6 ± 6.6 mm vs. 19.0 ± 6.9 mm, P < 0.001), shorter minor diameter (5.7 ± 2.9 mm vs. 10.7 ± 3.4 mm, P < 0.001), and lower percentage of lesions with Gleason pattern 5 (17% vs. 71%, P < 0.001). Shorter minor diameter (odds ratio [OR], 2.62; P = 0.04) and lower percentage of Gleason pattern 5 (OR, 24; P = 0.01) were independent predictors of MRI-undetectable csPC.
Conclusion: The pathological features of MRI-undetectable csPC included shorter minor diameter and lower percentage of Gleason pattern 5. csPC with shorter minor diameter may not be detected on mpMRI. Some MRI-undetectable csPC lesions exhibited sufficient size and Gleason pattern 5, emphasizing the need for further understanding of pathological factors contributing to MRI detectability.
期刊介绍:
The Journal of Clinical Imaging Science (JCIS) is an open access peer-reviewed journal committed to publishing high-quality articles in the field of Imaging Science. The journal aims to present Imaging Science and relevant clinical information in an understandable and useful format. The journal is owned and published by the Scientific Scholar. Audience Our audience includes Radiologists, Researchers, Clinicians, medical professionals and students. Review process JCIS has a highly rigorous peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel and important. Authors disclose all conflicts, affiliations and financial associations such that the published content is not biased.